HALOZYME THERAPEUTICS, INC. (HALO) › Shares OutstandingHALOZYME THERAPEUTICS, INC. (HALO) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2010: 100.58M2011: 103.99M2012: 112.71M2013: 114.53M2014: 125.72M2015: 128.15M2016: 129.50M2017: 142.79M2018: 144.73M2019: 136.71M2020: 135.03M2021: 137.50M2022: 135.15M2023: 126.77M2024: 123.14M2025: 117.78M117.78M2010Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY2025117.78M-4.3%2024123.14M-2.9%2023126.77M-6.2%2022135.15M-1.7%2021137.50M+1.8%2020135.03M-1.2%2019136.71M-5.5%2018144.73M+1.4%2017142.79M+10.3%2016129.50M+1.1%2015128.15M+1.9%2014125.72M+9.8%2013114.53M+1.6%2012112.71M+8.4%2011103.99M+3.4%2010100.58M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share